Tabla 3:
Resultados de laboratorio en el momento del ingreso hospitalario.
| Total n=197 | Leves n=127 | Graves n=70 | p | |
|---|---|---|---|---|
| Parámetros analíticos, mediana, IQR | ||||
| Leucocitos, × 109/L | 6,76 (4,78–9,10) | 6,15 (4,30–7,84) | 8,74 (6,14–11,93) | <0,001 |
| Linfocitos, × 109/L | 0,96 (0,75–1,34) | 1,01 (0,77–1,31) | 0,91 (0,63–1,44) | 0,320 |
| Neutrófilos, × 109/L | 5,35 (3,15–7,48) | 4,49 (2,79–6,25) | 7,23 (4,34–10,67) | <0,001 |
| Hemoglobina, g/L | 131 (119–144) | 133 (121–146) | 126 (115–137) | 0,004 |
| Plaquetas, × 109/L | 203 (158–271) | 201 (157–269) | 209 (160–275) | 0,496 |
| VSG, mm/h | 47 (16–70) | 36 (15–64) | 56 (19–84) | 0,024 |
| TP, s | 12,0 (11,4–13,0) | 11,9 (11,4–12,6) | 12,6 (11,8–13,7) | 0,002 |
| TTPA, s | 32,1 (28,8–37,0) | 31,4 (28,5–36,0) | 33,4 (29,8–38,2) | 0,047 |
| Dímero D, mg/L | 0,91 (0,54–1,92) | 0,80 (0,47–1,38) | 1,54 (0,71–3,42) | <0,001 |
| Creatinina, µmol/L | 83,1 (63,6–115,8) | 76,9 (63,6–104,3) | 107,9 (72,5–136,1) | 0,001 |
| Bilirrubina total, µmol/L | 6,8 (5,1–10,3) | 6,8 (5,1–10,3) | 7,7 (5,1–12,5) | 0,009 |
| ALT, U/L | 23,0 (14,0–34,4) | 23,0 (14,1–34,0) | 23,0 (13,6–37,0) | 0,968 |
| AST, U/L | 33 (23–50) | 31 (23–46) | 36 (23–54) | 0,331 |
| GGT, U/L | 39 (23–86) | 31 (21–67) | 54 (29–125) | 0,002 |
| LDH, U/L | 294 (238–411) | 288 (234–365) | 322 (242–538) | 0,023 |
| PCR, mg/L | 69,3 (24,4–140,8) | 51,3 (17,9–120,5) | 117,6 (50,2–247,8) | <0,001 |
| PCT, ng/mL | 0,12 (0,08–0,29) | 0,09 (0,06–0,14) | 0,31 (0,16–0,73) | <0,001 |
| Ferritina, µg/L | 507 (244–1052) | 462 (224–781) | 677 (276–1335) | 0,012 |
VSG, velocidad de sedimentación globular; TP, tiempo de protrombina; TTPA, tiempo de tromboplastina parcial activada; ALT, alanina aminotransferasa; AST, aspartato aminotransferasa; GGT, γ-glutamiltransferasa; LDH, lactato deshidrogenasa; PCR, proteína C reactiva; PCT, procalcitonina.